Gerresheimer AG

Gerresheimer with positive start to the financial year 2021

- Organic revenue growth of 3.1 % in core business

OTE0001
08.04.2021 08:53
 
OTE0001
13.10.2020 07:33
 

Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share

Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG.

OTE0003
24.06.2020 16:44
 

New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical

Sensile Medical, a subsidiary of Gerresheimer AG, has signed a contract with the Swiss biopharma­ceutical company SQ Innovation AG for the development, market launch and mass production of a micro pump for …

OTE0003
19.11.2019 13:38
 

Gerresheimer Reports Strong Second Quarter

Gerresheimer AG closed the second quarter of the financial year 2019 (March 1, 2019 to May 31, 2019) with strong revenue growth. "We had a successful second quarter.

OTE0004
11.07.2019 08:10
 

Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.

OTE0001
14.05.2019 10:32
 

Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

* Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m

OTE0003
11.10.2018 08:05